Literature DB >> 12204597

Immunomodulating activities of soluble synthetic polymer-bound drugs.

Blanka Ríhová1.   

Abstract

The introduction of a synthetic material into the body always affects different body systems, including the defense system. Synthetic polymers are usually thymus-independent antigens with only a limited ability to elicit antibody formation or to induce a cellular immune response against them. However, there are many other ways that they influence or can be used to influence the immune system of the host. Low-immunogenic water-soluble synthetic polymers sometimes exhibit significant immunomodulating activity, mainly concerning the activation/suppression of NK cells, LAK cells and macrophages. Some of them, such as poly(ethylene glycol) and poly[N-(2-hydroxypropyl)methacrylamide], can be used as effective protein carriers, as they are able to reduce the immunogenicity of conjugated proteins and/or to reduce non-specific uptake of liposome/nanoparticle-entrapped drugs and other therapeutic agents. Recently, the development of vaccine delivery systems prepared from biodegradable and biocompatible water-soluble synthetic polymers, microspheres, liposomes and/or nanoparticles has received considerable attention, as they can be tailored to meet the specific physical, chemical, and immunogenic requirements of a particular antigen and some of them can also act as adjuvants. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12204597     DOI: 10.1016/s0169-409x(02)00043-1

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  10 in total

Review 1.  Immunological risk of injectable drug delivery systems.

Authors:  Wim Jiskoot; Rianne M F van Schie; Myrra G Carstens; Huub Schellekens
Journal:  Pharm Res       Date:  2009-02-27       Impact factor: 4.200

2.  Variable antibody-dependent activation of complement by functionalized phospholipid nanoparticle surfaces.

Authors:  Christine T N Pham; Lynne M Mitchell; Jennifer L Huang; Christopher M Lubniewski; Otto F Schall; J Kendall Killgore; Dipanjan Pan; Samuel A Wickline; Gregory M Lanza; Dennis E Hourcade
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

Review 3.  Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines.

Authors:  Marina A Dobrovolskaia; Scott E McNeil
Journal:  J Control Release       Date:  2013-06-03       Impact factor: 9.776

4.  Doxorubicin attached to HPMA copolymer via amide bond modifies the glycosylation pattern of EL4 cells.

Authors:  Lubomir Kovar; Tomas Etrych; Martina Kabesova; Vladimir Subr; David Vetvicka; Ondrej Hovorka; Jiri Strohalm; Jan Sklenar; Petr Chytil; Karel Ulbrich; Blanka Rihova
Journal:  Tumour Biol       Date:  2010-02-24

5.  Multi-component polymeric system for tumour cell-specific gene delivery using a universal bungarotoxin linker.

Authors:  Ralph A Willemsen; Michal Pechar; Robert C Carlisle; Erik Schooten; Robert Pola; Amber J Thompson; Leonard W Seymour; Karel Ulbrich
Journal:  Pharm Res       Date:  2010-03-19       Impact factor: 4.200

Review 6.  Designer lipids for drug delivery: from heads to tails.

Authors:  Aditya G Kohli; Paul H Kierstead; Vincent J Venditto; Colin L Walsh; Francis C Szoka
Journal:  J Control Release       Date:  2014-05-06       Impact factor: 9.776

7.  Preclinical evaluation of linear HPMA-doxorubicin conjugates with pH-sensitive drug release: efficacy, safety, and immunomodulating activity in murine model.

Authors:  Milada Sirova; Tomas Mrkvan; Tomas Etrych; Petr Chytil; Pavel Rossmann; Marketa Ibrahimova; Lubomir Kovar; Karel Ulbrich; Blanka Rihova
Journal:  Pharm Res       Date:  2009-11-06       Impact factor: 4.200

8.  Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers.

Authors:  Elena V Batrakova; Shu Li; Anna M Brynskikh; Amit K Sharma; Yili Li; Michael Boska; Nan Gong; R Lee Mosley; Valery Yu Alakhov; Howard E Gendelman; Alexander V Kabanov
Journal:  J Control Release       Date:  2010-01-13       Impact factor: 9.776

9.  HPMA copolymers: origins, early developments, present, and future.

Authors:  Jindrich Kopecek; Pavla Kopecková
Journal:  Adv Drug Deliv Rev       Date:  2009-11-14       Impact factor: 15.470

10.  One-step nanomorphology control of self-organized projection coronas in uniform polymeric nanoparticles.

Authors:  Kazuhiro Hamada; Tatsuo Kaneko; Ming Qing Chen; Mitsuru Akashi
Journal:  Polymer (Guildf)       Date:  2005-11-09       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.